Reliance Chemotex FY26 Profit Rises 30% to ₹5.26 Cr, Declares ₹0.50 Dividend

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Reliance Chemotex FY26 Profit Rises 30% to ₹5.26 Cr, Declares ₹0.50 Dividend
Overview

Reliance Chemotex Industries reported a 30% year-over-year increase in net profit to ₹5.26 crore for FY26. The company also announced a final dividend of ₹0.50 per share, subject to shareholder approval.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Reliance Chemotex Reports Strong FY26 Performance with Profit Growth and Dividend

Net Profit FY2026: ₹5.26 crore
Revenue from Operations FY2026: ₹362.01 crore

Reader Takeaway: Profitability improved with revenue growth; dividend payout offers direct returns.

What just happened

Reliance Chemotex Industries Limited announced its audited financial results for the year ended March 31, 2026. The company posted a net profit of ₹5.26 crore, a significant increase from ₹4.04 crore in the previous financial year. Revenue from operations grew to ₹362.01 crore from ₹358.60 crore.

The company's Board of Directors has recommended a final dividend of ₹0.50 per equity share of ₹10 face value, pending shareholder approval.

Why this matters

The 30% rise in net profit demonstrates improved financial health and operational efficiency. The dividend payout offers a direct return to shareholders, making the stock more attractive.

The backstory

In FY2026, Reliance Chemotex saw its revenue from operations reach ₹362.01 crore, a marginal increase from ₹358.60 crore in FY2025. Net profit grew substantially to ₹5.26 crore, up from ₹4.04 crore in the prior year. The company's total assets also expanded to ₹511.96 crore as of March 31, 2026, from ₹474.36 crore a year earlier.

What changes now

Reliance Chemotex will transition to a new tax regime under Section 115BAA of the Income-tax Act, effective FY2026-27. This move resulted in a net reversal of deferred tax liabilities of ₹0.77 crore, positively impacting the current year's results.

Risks to watch

While performance has improved, investors should monitor the company's ability to sustain profit margins and effectively leverage the new tax regime for future benefits.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

Net cash flow from operating activities improved to ₹21.65 crore in FY2026 from ₹10.81 crore in FY2025.

What to track next

Investors should watch for the approval of the final dividend and the company's execution strategy under the new tax regime in the upcoming financial year.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.